Biogen Inc. buy hoffi69
Start price
01.11.12
/
50%
€106.94
Target price
01.02.13
€120.00
Performance (%)
6.61%
End price
01.02.13
€114.00
Summary
This prediction ended on 01.02.13 with a price of €114.00. With a performance of 6.61%, the BUY prediction by hoffi69 for Biogen Inc. closed with a slight gain. hoffi69 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 2.463% | 2.463% | 16.433% | -32.732% |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% | 53.022% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% | 95.411% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% | 54.646% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% | 66.550% |
Comments by hoffi69 for this prediction
In the thread Biogen Inc. diskutieren
Megatrend
(Reuptake) Ähnlich wie Amgen steht auch Biogen grundsolide da.In den Megatrend molekularbiologisch/gentechnisch hergestellter Medikamente lohnt es sich nach dem Rücksetzer bei Biogen einzusteigen.Die Nachfrage wird weiter steigen.
(Vom Mitglied beendet)